Immune Thrombocytopenia Treatment: The Role of Fostamatinib Tablets
Immune thrombocytopenia treatment has evolved significantly, with fostamatinib tablets emerging as a targeted therapy for patients with chronic ITP. Immune thrombocytopenia treatment with fostamatinib, a SYK inhibitor drug, provides an important alternative for patients who have not responded to other treatments. The global market for fostamatinib tablets is projected to grow from USD...
0 Comments 0 Shares 111 Views 0 Reviews